farmakovigilija

Farmakovigilija is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problem. It is a crucial component of public health, ensuring that medicines remain safe for their intended use throughout their lifecycle. The primary goal of farmakovigilija is to identify potential risks associated with medicines as early as possible and to implement measures to protect patients.

This process involves collecting information on suspected adverse drug reactions (ADRs) from various sources, including healthcare professionals, patients, and pharmaceutical companies. These reports are then analyzed to identify patterns, assess the severity of the reactions, and determine if there is a causal link to the medication. Based on this assessment, regulatory authorities can take appropriate actions, such as updating product information, issuing warnings, restricting the use of the drug, or even withdrawing it from the market if the risks outweigh the benefits.

Farmakovigilija activities are essential for maintaining the benefit-risk balance of medicines. It contributes to the safe and effective use of pharmaceuticals by providing ongoing monitoring after a medicine has been approved and marketed. This continuous surveillance helps to detect rare or long-term side effects that may not have been apparent during clinical trials. Ultimately, farmakovigilija plays a vital role in safeguarding public health by ensuring that the medicines available to patients are both effective and as safe as possible.